{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:39:20Z","timestamp":1788817160094,"version":"build-2803163510"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/002746"],"award-info":[{"award-number":["CRG\/2022\/002746"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijbiomac.2024.134097","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T03:42:44Z","timestamp":1721878964000},"page":"134097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["A comprehensive review on the current status of CRISPR based clinical trials for rare diseases"],"prefix":"10.1016","volume":"277","author":[{"given":"Amneet Kaur","family":"Badwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.134097_bb0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0010","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/bloodadvances.2020001996","article-title":"Correction of \u03b2-thalassemia by CRISPR\/Cas9 editing of the \u03b1-globin locus in human hematopoietic stem cells","volume":"5","author":"Pavani","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0015","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1172\/JCI92087","article-title":"CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease","volume":"127","author":"Yang","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41551-023-01007-3","article-title":"Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington\u2019s disease","volume":"7","author":"Yan","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0025","unstructured":"Orphanet: quality charter about rare diseases, (n.d.). https:\/\/www.orpha.net\/en\/other-information\/about-rare-diseases (accessed March 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.21037\/atm.2018.09.04","article-title":"Rare diseases: the paradox of an emerging challenge","volume":"6","author":"Danese","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0035","unstructured":"Orphadata \u2014 Orphanet datasets, (n.d.). https:\/\/www.orphadata.com\/ (accessed June 3, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0040","author":"IORD - Indian Organization for Rare Diseases"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0045","unstructured":"Metropolis Healthcare. Rare disease: what is it? Causes & diagnosis, (n.d.). https:\/\/www.metropolisindia.com\/blog\/preventive-healthcare\/rare-disease-what-is-it-causes-and-diagnosis (accessed March 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0050","series-title":"Rare Diseases and Orphan Products: Accelerating Research and Development","article-title":"Profile of rare diseases","author":"Institute of Medicine (US) Committee on Accelerating Rare Diseases Research and Orphan Product Development","year":"2010"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0055","unstructured":"Orphanet: diseases, (n.d.). https:\/\/www.orpha.net\/en\/disease (accessed March 11, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0060","author":"Zeidler"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/bio.2020.0108","article-title":"An overview of benefits and challenges of rare disease biobanking in Africa, focusing on South Africa","volume":"19","author":"Conradie","year":"2021","journal-title":"Biopreserv. Biobank."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13023-017-0618-0","article-title":"Review of 11 national policies for rare diseases in the context of key patient needs","volume":"12","author":"Dharssi","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0075","unstructured":"Orphan diseases: physical and emotional impact, (n.d.). https:\/\/artritispr.com\/articulos\/enfermedades-huerfanas-impacto-fisico-y-emocional\/ (accessed June 3, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0080","unstructured":"Liljesthr\u00f6m M., Armando R., Maier B., Robert F., Zelikman D., Rare Diseases in Argentina: What a Survey of Families Tell Us About the Diagnosis Process, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0085","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/s41436-020-0845-y","article-title":"Automated syndrome diagnosis by three-dimensional facial imaging","volume":"22","author":"Hallgr\u00edmsson","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-020-01374-z","article-title":"Diagnosis support systems for rare diseases: a scoping review","volume":"15","author":"Faviez","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ajhg.2009.09.003","article-title":"Clinical diagnostics in human genetics with semantic similarity searches in ontologies","volume":"85","author":"K\u00f6hler","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijmedinf.2013.01.005","article-title":"FindZebra: a search engine for rare diseases","volume":"82","author":"Dragusin","year":"2013","journal-title":"Int. J. Med. Inform."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nmeth.3484","article-title":"Phenolyzer: phenotype-based prioritization of candidate genes for human diseases","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2018.08.003","article-title":"PubCaseFinder: a case-report-based, phenotype-driven differential-diagnosis system for rare diseases","volume":"103","author":"Fujiwara","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0115","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/s41436-019-0439-8","article-title":"Xrare: a machine learning method jointly modeling phenotypes and genetic evidence for rare disease diagnosis","volume":"21","author":"Li","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0120","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41436-018-0050-4","article-title":"Novel phenotype-disease matching tool for rare genetic diseases","volume":"21","author":"Chen","year":"2019","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0125","unstructured":"Novartis. Spinal muscular atrophy (SMA) (n.d.). https:\/\/www.novartis.com\/diseases\/spinal-muscular-atrophy-sma (accessed June 4, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0130","unstructured":"NORD. Bachmann-Bupp syndrome \u2014 symptoms, causes, treatment, (n.d.). https:\/\/rarediseases.org\/rare-diseases\/bachmann-bupp-syndrome\/ (accessed April 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0135","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1002\/jcph.2134","article-title":"Natural history and real-world data in rare diseases: applications, limitations, and future perspectives","volume":"62","author":"Liu","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0140","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.drudis.2013.10.012","article-title":"Big data in biomedicine","volume":"19","author":"Costa","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0150","unstructured":"ScienceDirect Topics. Whole Exome Sequencing \u2014 an overview, (n.d.). https:\/\/www.sciencedirect.com\/topics\/immunology-and-microbiology\/whole-exome-sequencing (accessed March 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0155","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0165","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product","volume":"169","author":"Ishino","year":"1987","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0170","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-mediated genome editing increases lifespan and improves motor deficits in a Huntington\u2019s disease mouse model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0175","doi-asserted-by":"crossref","first-page":"35588","DOI":"10.1074\/jbc.M506654200","article-title":"Development of zinc finger domains for recognition of the 5\u2032-CNN-3\u2032 family DNA sequences and their use in the construction of artificial transcription factors","volume":"280","author":"Dreier","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nmeth.1670","article-title":"Revealing off-target cleavage specificities of zinc finger nucleases by in vitro selection","volume":"8","author":"Pattanayak","year":"2011","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0185","doi-asserted-by":"crossref","unstructured":"A Practical Guide to Genome Editing Using Targeted Nuclease Technologies \u2013 Porter \u2013 Major Reference Works. Wiley Online Library, (n.d.). https:\/\/doi.org\/10.1002\/cphy.c180022 (accessed June 6, 2024).","DOI":"10.1002\/cphy.c180022"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0190","unstructured":"Zinc-finger Nucleases: the next generation emerges: molecular therapy, (n.d.). https:\/\/www.cell.com\/molecular-therapy-family\/molecular-therapy\/fulltext\/S1525-0016(16)32459-5 (accessed June 6, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0195","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1021\/bi200393g","article-title":"Adding fingers to an engineered zinc finger nuclease can reduce activity","volume":"50","author":"Shimizu","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0200","unstructured":"ScienceDirect. TALE nucleases: tailored genome engineering made easy, (n.d.). https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0958166912000286 (accessed June 6, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0205","doi-asserted-by":"crossref","first-page":"E6736","DOI":"10.1073\/pnas.1521077112","article-title":"Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi","volume":"112","author":"Gantz","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/156652311794520120","article-title":"Zinc-finger nuclease based genome surgery: it\u2019s all about specificity","volume":"11","author":"Handel","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0215","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/stem.718","article-title":"In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases","volume":"29","author":"Sebastiano","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0220","unstructured":"Nature. Highly efficient endogenous human gene correction using designed zinc-finger nucleases (n.d.). https:\/\/www.nature.com\/articles\/nature03556 (accessed June 6, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0225","doi-asserted-by":"crossref","unstructured":"Science. Breaking the code of DNA binding specificity of TAL-type III effectors (n.d.). https:\/\/doi.org\/10.1126\/science.1178811 (accessed June 20, 2024).","DOI":"10.1126\/science.1178811"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0378-1119(81)90062-7","article-title":"New restriction endonucleases from Flavobacterium okeanokoites (FokI) and Micrococcus luteus (MluI)","volume":"16","author":"Sugisaki","year":"1981","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0235","unstructured":"PubMed. A simple cipher governs DNA recognition by TAL effectors (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/19933106\/ (accessed June 20, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0240","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1126\/science.1215670","article-title":"Structural basis for sequence-specific recognition of DNA by TAL effectors","volume":"335","author":"Deng","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0245","doi-asserted-by":"crossref","unstructured":"SpringerLink, Design, Construction, and Application of Transcription Activation-like Effectors (n.d.). https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_3 (accessed June 6, 2024).","DOI":"10.1007\/978-1-4939-9065-8_3"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0250","doi-asserted-by":"crossref","unstructured":"SpringerLink. The Development of TALE Nucleases for Biotechnology (n.d.). https:\/\/doi.org\/10.1007\/978-1-4939-2932-0_3 (accessed June 6, 2024).","DOI":"10.1007\/978-1-4939-2932-0_3"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0255","doi-asserted-by":"crossref","first-page":"W52","DOI":"10.1093\/nar\/gkm360","article-title":"CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats","volume":"35","author":"Grissa","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0260","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1099\/mic.0.28048-0","article-title":"Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin","volume":"151","author":"Bolotin","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0265","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements","volume":"60","author":"Mojica","year":"2005","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/mic.0.27437-0","article-title":"CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies","volume":"151","author":"Pourcel","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41579-019-0299-x","article-title":"Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants","volume":"18","author":"Makarova","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0280","doi-asserted-by":"crossref","first-page":"aad5147","DOI":"10.1126\/science.aad5147","article-title":"Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems","volume":"353","author":"Mohanraju","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0285","unstructured":"PubMed. Introducing a Spectrum of Long-range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30975459\/ (accessed June 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0290","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1038\/s41467-019-13226-x","article-title":"CRISPR-Cas3 induces broad and unidirectional genome editing in human cells","volume":"10","author":"Morisaka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0295","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1093\/nar\/gkab348","article-title":"Genome editing in mammalian cells using the CRISPR type I-D nuclease","volume":"49","author":"Osakabe","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0300","unstructured":"PMC, Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8964063\/ (accessed June 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0305","unstructured":"PubMed, A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30581144\/ (accessed June 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0310","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/femsre\/fuv023","article-title":"Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity","volume":"39","author":"Charpentier","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mib.2017.05.008","article-title":"Diversity, classification and evolution of CRISPR-Cas systems","volume":"37","author":"Koonin","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0320","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrmicro3569","article-title":"An updated evolutionary classification of CRISPR-Cas systems","volume":"13","author":"Makarova","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0339-7","article-title":"Recent advances in the CRISPR genome editing tool set","volume":"51","author":"Moon","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41564-018-0274-8","article-title":"Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum","volume":"4","author":"\u00d6zcan","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0335","unstructured":"PubMed, CRISPR-Cas orthologues and variants: optimizing the repertoire, specificity and delivery of genome engineering tools (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28634692\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0340","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1093\/nar\/gku241","article-title":"Classification and evolution of type II CRISPR-Cas systems","volume":"42","author":"Chylinski","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0345","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/acschembio.7b00855","article-title":"Type II-C CRISPR-Cas9 biology, mechanism, and application","volume":"13","author":"Mir","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0350","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.tibtech.2016.02.004","article-title":"Next generation prokaryotic engineering: the CRISPR-Cas toolkit","volume":"34","author":"Mougiakos","year":"2016","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0355","unstructured":"PubMed, Conformational control of DNA target cleavage by CRISPR-Cas9 (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/26524520\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0360","unstructured":"PubMed, Direct observation of R-loop formation by single RNA-guided Cas9 and cascade effector complexes (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/24912165\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0365","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1093\/nar\/gkv601","article-title":"Development of an intein-mediated split-Cas9 system for gene therapy","volume":"43","author":"Truong","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0370","unstructured":"PubMed, Cas9-catalyzed DNA cleavage generates staggered ends: evidence from molecular dynamics simulations (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27874072\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0375","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cell.2015.09.011","article-title":"SnapShot: CRISPR-RNA-guided adaptive immune systems","volume":"163","author":"Carter","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0380","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1365-2958.2012.08171.x","article-title":"Selective and hyperactive uptake of foreign DNA by adaptive immune systems of an archaeon via two distinct mechanisms","volume":"85","author":"Erdmann","year":"2012","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0385","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/nar\/gku1383","article-title":"Transcriptional regulator-mediated activation of adaptation genes triggers CRISPR de novo spacer acquisition","volume":"43","author":"Liu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0390","doi-asserted-by":"crossref","unstructured":"PLOS ONE. CRISPR Interference Directs Strand Specific Spacer Acquisition (n.d.). https:\/\/doi.org\/10.1371\/journal.pone.0035888 (accessed April 3, 2024).","DOI":"10.1371\/journal.pone.0035888"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0395","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1093\/nar\/gks216","article-title":"Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli","volume":"40","author":"Yosef","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0400","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ncomms1937","article-title":"Molecular memory of prior infections activates the CRISPR\/Cas adaptive bacterial immunity system","volume":"3","author":"Datsenko","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0405","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1128\/JB.01184-12","article-title":"The CRISPR\/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages","volume":"194","author":"Cady","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0410","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1365-2958.2010.07073.x","article-title":"Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS","volume":"75","author":"Pul","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0415","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molcel.2011.10.023","article-title":"Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs","volume":"45","author":"Hale","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0420","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2958.2009.06641.x","article-title":"CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties","volume":"72","author":"Lillest\u00f8l","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0425","unstructured":"PubMed, Transcription, processing and function of CRISPR cassettes in Escherichia coli (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/20624226\/ (accessed April 19, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0430","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/15476286.2019.1582974","article-title":"CRISPR-Cas in Streptococcus pyogenes","volume":"16","author":"Le Rhun","year":"2019","journal-title":"RNA Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0435","doi-asserted-by":"crossref","first-page":"21218","DOI":"10.1073\/pnas.1112832108","article-title":"Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site","volume":"108","author":"Hatoum-Aslan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0440","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1126\/science.1165771","article-title":"CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA","volume":"322","author":"Marraffini","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0445","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.molcel.2011.12.013","article-title":"Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity","volume":"45","author":"Zhang","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0450","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0455","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-biophys-062215-010822","article-title":"CRISPR-Cas9 structures and mechanisms","volume":"46","author":"Jiang","year":"2017","journal-title":"Annu. Rev. Biophys."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0460","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of Cas9 in complex with guide RNA and target DNA","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0465","unstructured":"PubMed. Structural biology. A Cas9-guide RNA complex preorganized for target DNA recognition (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/26113724\/ (accessed June 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0470","doi-asserted-by":"crossref","first-page":"1247997","DOI":"10.1126\/science.1247997","article-title":"Structures of Cas9 endonucleases reveal RNA-mediated conformational activation","volume":"343","author":"Jinek","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0475","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature13011","article-title":"DNA interrogation by the CRISPR RNA-guided endonuclease Cas9","volume":"507","author":"Sternberg","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0480","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1126\/science.aad8282","article-title":"Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage","volume":"351","author":"Jiang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0485","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0490","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1021\/jacs.7b13050","article-title":"Bidirectional degradation of DNA cleavage products catalyzed by CRISPR\/Cas9","volume":"140","author":"Stephenson","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0495","unstructured":"PubMed. Functional insights revealed by the kinetic mechanism of CRISPR\/Cas9. (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/29442507\/ (accessed June 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0500","first-page":"1559","article-title":"Genome editing: a perspective on the application of CRISPR\/Cas9 to study human diseases (review)","volume":"43","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0505","unstructured":"PubMed. Type II and type V CRISPR effector nucleases from a structural biologist's perspective (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28132486\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0510","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature17945","article-title":"The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA","volume":"532","author":"Fonfara","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0515","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aav4294","article-title":"Programmed DNA destruction by miniature CRISPR-Cas14 enzymes","volume":"362","author":"Harrington","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0520","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1093\/nar\/gkaa208","article-title":"PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage","volume":"48","author":"Karvelis","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0525","unstructured":"PubMed. CasX enzymes comprise a distinct family of RNA-guided genome editors (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30718774\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0530","unstructured":"PubMed. C2c1-sgRNA complex structure reveals RNA-guided DNA cleavage mechanism (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27989439\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0535","unstructured":"PubMed. Engineering of CRISPR-Cas12b for human genome editing (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30670702\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0540","unstructured":"PubMed. Structural basis for guide RNA processing and seed-dependent DNA targeting by CRISPR-Cas12a, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28431230\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0545","unstructured":"PubMed. Repurposing CRISPR-Cas12b for mammalian genome engineering (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30510770\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0550","unstructured":"PubMed. Crystal structure of Cpf1 in complex with guide RNA and target DNA (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27114038\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0555","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.aav7271","article-title":"Functionally diverse type V CRISPR-Cas systems","volume":"363","author":"Yan","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0560","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cell.2016.11.053","article-title":"PAM-dependent target DNA recognition and cleavage by C2c1 CRISPR-Cas endonuclease","volume":"167","author":"Yang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0565","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0570","unstructured":"PubMed. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27256883\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0575","unstructured":"PubMed. RNA targeting by functionally orthogonal type VI-A CRISPR-Cas enzymes, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/28475872\/ (accessed June 8, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0580","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0585","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jmb.2018.06.029","article-title":"Molecular mechanisms of RNA targeting by Cas13-containing type VI CRISPR-Cas systems","volume":"431","author":"O\u2019Connell","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0590","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0595","unstructured":"Various aspects of a gene editing system\u2014CRISPR\u2013Cas9 (PDF) (n.d.). https:\/\/www.researchgate.net\/publication\/347668474_Various_Aspects_of_a_Gene_Editing_System-CRISPR-Cas9 (accessed June 6, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.673286","article-title":"Nanoparticle delivery of CRISPR\/Cas9 for genome editing","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0605","doi-asserted-by":"crossref","first-page":"AB147","DOI":"10.1016\/j.jaci.2020.12.531","article-title":"NTLA-2002: CRISPR\/Cas9-mediated gene knockout of KLKB1 to treat hereditary angioedema","volume":"147","author":"Seitzer","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0610","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.apsb.2021.05.020","article-title":"In vivo delivery of CRISPR-Cas9 therapeutics: progress and challenges","volume":"11","author":"Behr","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0615","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2022.01.013","article-title":"Delivery of CRISPR-Cas tools for in vivo genome editing therapy: trends and challenges","volume":"342","author":"Taha","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0620","doi-asserted-by":"crossref","first-page":"dmm039982","DOI":"10.1242\/dmm.039982","article-title":"CRISPR\/Cas9-mediated genome editing in nonhuman primates","volume":"12","author":"Kang","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0625","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/hmg\/ddx154","article-title":"Quantitative assessment of timing, efficiency, specificity and genetic mosaicism of CRISPR\/Cas9-mediated gene editing of hemoglobin beta gene in rhesus monkey embryos","volume":"26","author":"Midic","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0630","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s42003-021-01942-4","article-title":"Efficacy and long-term safety of CRISPR\/Cas9 genome editing in the SOD1-linked mouse models of ALS","volume":"4","author":"Deng","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0635","article-title":"How to obtain the P value from a confidence interval","volume":"343","author":"Altman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278539","article-title":"Feasibility of combining short tandem repeats (STRs) haplotyping with preimplantation genetic diagnosis (PGD) in screening for beta thalassemia","volume":"17","author":"Vuong","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0650","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243518","article-title":"Bernard Soulier syndrome: a rare, frequently misdiagnosed and poorly managed bleeding disorder","volume":"14","author":"Monteiro","year":"2021","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0655","doi-asserted-by":"crossref","DOI":"10.34172\/ipp.2023.39490","article-title":"Neurological complications as the hallmark symptoms of thrombotic thrombocytopenic purpura in sickle cell disease","author":"Bahadoram","year":"2023","journal-title":"Immunopathol. Persa"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101820","article-title":"Impact of iron overload in hematopoietic stem cell transplantation","volume":"78","author":"Wang","year":"2023","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730873","article-title":"The future of gene therapy for transfusion-dependent beta-thalassemia: the power of the lentiviral vector for genetically modified hematopoietic stem cells","volume":"12","author":"Rattananon","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0670","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0675","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1182\/blood-2014-08-435768","article-title":"Update on the use of hydroxyurea therapy in sickle cell disease","volume":"124","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0680","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/17474086.2014.959922","article-title":"Hydroxyurea therapy contributes to infertility in adult men with sickle cell disease: a review, Expert","volume":"7","author":"DeBaun","year":"2014","journal-title":"Rev. Hematol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0685","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2015.10.017","article-title":"Indications and results of HLA-identical sibling hematopoietic cell transplantation for sickle cell disease","volume":"22","author":"Walters","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0690","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","article-title":"Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation","volume":"129","author":"Gluckman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0695","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0700","unstructured":"PubMed. An update on the genetics and pathogenesis of hereditary angioedema (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/32181278\/ (accessed April 18, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0705","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaci.2018.01.015","article-title":"Hereditary angioedema with normal C1 inhibitor: four types and counting","volume":"141","author":"Zuraw","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0710","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41598-017-16667-w","article-title":"Intermittent C1-inhibitor deficiency associated with recessive inheritance: functional and structural insight","volume":"8","author":"Caccia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0715","unstructured":"PMC. Use of CRISPR\/Cas9 to model brain diseases (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5630495\/ (accessed June 21, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0720","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","article-title":"Hereditary transthyretin amyloidosis overview","volume":"43","author":"Manganelli","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0725","doi-asserted-by":"crossref","first-page":"B99","DOI":"10.1093\/eurheartjsupp\/suad082","article-title":"Treatment of amyloidosis: present and future","volume":"25","author":"Mallus","year":"2023","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0730","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0735","unstructured":"SEER. Rare cancer classification \u2014 SEER recodes (n.d.). https:\/\/seer.cancer.gov\/seerstat\/variables\/seer\/raresiterecode\/index.html (accessed March 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0740","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ijms25021201","article-title":"An overview of advances in rare cancer diagnosis and treatment","volume":"25","author":"Christyani","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0745","series-title":"StatPearls","article-title":"Relapsed and refractory multiple myeloma","author":"Ahmed","year":"2024"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0750","unstructured":"NORD. Hepatocellular carcinoma \u2014 symptoms, causes, treatment (n.d.). https:\/\/rarediseases.org\/rare-diseases\/hepatocellular-carcinoma\/ (accessed March 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0755","unstructured":"Nature Genetics. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes (n.d.). https:\/\/www.nature.com\/articles\/ng.3126 (accessed April 18, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0760","unstructured":"Nature Genetics. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets (n.d.). https:\/\/www.nature.com\/articles\/ng.3252 (accessed April 18, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0765","doi-asserted-by":"crossref","unstructured":"M. Marzban, M. Bahrami, M. Kamalinejad, M. Tahamtan, N. Khavasi, M. Haji Monfared, M. Jameshorani, The therapeutic effects of chicory seed aqueous extract on cardio-metabolic profile and liver enzymes in nonalcoholic fatty liver disease; a double blind randomized clinical trial, Immunopathol. Persa (2022) 1. doi:10.34172\/ipp.2022.28262.","DOI":"10.34172\/ipp.2022.28262"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0770","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0775","unstructured":"NORD. Mantle cell lymphoma \u2014 symptoms, causes, treatment, (n.d.). https:\/\/rarediseases.org\/rare-diseases\/mantle-cell-lymphoma\/ (accessed June 22, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0780","author":"National Organization for Rare Disorders"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0785","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13312-021-2210-x","article-title":"Estimated national and state level incidence of childhood and adolescent cancer in India","volume":"58","author":"Arora","year":"2021","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0790","series-title":"Leukemia","article-title":"Genetics of acute lymphoblastic leukemia","author":"Forero","year":"2013"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0795","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4103\/ijo.IJO_322_22","article-title":"Rare eye diseases in India: a concise review of genes and genetics","volume":"70","author":"Jeyabalan","year":"2022","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0800","unstructured":"S. Dharmaraj, E. Silva, A.L. Pina, Y.Y. Li, J.-M. Yang, R.C. Carter, M. Loyer, H. El-Hilali, E. Traboulsi, O. Sundin, D. Zhu, R.K. Koenekoop, I.H. Maumenee, Mutational Analysis and Clinical Correlation in Leber Congenital Amaurosis, (n.d.)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0805","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/IAE.0000000000003133","article-title":"Leber congenital amaurosis due to CEP290 mutations\u2014severe vision impairment with a high unmet medical need","volume":"41","author":"Leroy","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0810","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3390\/genes12070968","article-title":"Rubinstein-Taybi syndrome: a model of epigenetic disorder","volume":"12","author":"Van Gils","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0815","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/376348a0","article-title":"Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP","volume":"376","author":"Petrif","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0820","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/429130","article-title":"Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease","volume":"76","author":"Roelfsema","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0825","unstructured":"NORD. Rubinstein-Taybi syndrome \u2014 symptoms, causes, treatment, (n.d.). https:\/\/rarediseases.org\/rare-diseases\/rubinstein-taybi-syndrome\/ (accessed June 22, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0830","unstructured":"NORD. Duchenne muscular dystrophy \u2014 symptoms, causes, treatment, (n.d.). https:\/\/rarediseases.org\/rare-diseases\/duchenne-muscular-dystrophy\/ (accessed April 21, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0835","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.3390\/life12121968","article-title":"CRISPR-based tools for fighting rare diseases","volume":"12","author":"Li","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0840","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of hematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0845","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nbt.4199","article-title":"An APOBEC3A-Cas9 base editor with minimized bystander and off-target activities","volume":"36","author":"Gehrke","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0850","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","article-title":"Directed evolution of adenine base editors with increased activity and therapeutic application","volume":"38","author":"Gaudelli","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0855","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1038\/s41467-021-24017-8","article-title":"AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0860","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","article-title":"Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase","volume":"72","author":"Yuan","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0865","doi-asserted-by":"crossref","first-page":"eabg4910","DOI":"10.1126\/sciadv.abg4910","article-title":"Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing","volume":"7","author":"Chemello","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0870","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ymthe.2017.05.015","article-title":"Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration","volume":"25","author":"Burnight","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0875","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/hmg\/ddaa106","article-title":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR\/Cas9 genome editing using homology-directed repair","volume":"29","author":"Ababneh","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0880","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-02729-0","article-title":"C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity","volume":"9","author":"Selvaraj","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0885","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","article-title":"CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs","volume":"8","author":"Wang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0890","doi-asserted-by":"crossref","unstructured":"Molecular Diagnosis & Therapy. Rare opportunities: CRISPR\/Cas-based therapy development for rare genetic diseases, (n.d.). https:\/\/doi.org\/10.1007\/s40291-019-00392-3 (accessed April 10, 2024).","DOI":"10.1007\/s40291-019-00392-3"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0895","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0900","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3389\/fpls.2018.01245","article-title":"The enhancement of plant disease resistance using CRISPR\/Cas9 technology","volume":"9","author":"Borrelli","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0905","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","article-title":"Optimizing genome editing strategy by primer-extension-mediated sequencing","volume":"5","author":"Yin","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0910","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41467-022-28244-5","article-title":"CRISPR-Cas9 induces large structural variants at on-target and off-target sites in vivo that segregate across generations","volume":"13","author":"H\u00f6ijer","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0915","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/hmg\/ddv120","article-title":"Functional disruption of the dystrophin gene in rhesus monkey using CRISPR\/Cas9","volume":"24","author":"Chen","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0920","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0925","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1101\/gr.089417.108","article-title":"Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly","volume":"19","author":"Kim","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0930","doi-asserted-by":"crossref","first-page":"1902312","DOI":"10.1002\/advs.201902312","article-title":"CRISPR\/Cas systems in genome editing: methodologies and tools for sgRNA design, off-target evaluation, and strategies to mitigate off-target effects","volume":"7","author":"Manghwar","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0935","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-0716-0290-4_19","article-title":"CRISPR\/Cas9 guide RNA design rules for predicting activity","volume":"2115","author":"Hiranniramol","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0940","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nbt.3026","article-title":"Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation","volume":"32","author":"Doench","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0945","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-015-0784-0","article-title":"WU-CRISPR: characteristics of functional guide RNAs for the CRISPR\/Cas9 system","volume":"16","author":"Wong","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0950","unstructured":"PubMed. Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAs, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/29216382\/ (accessed June 7, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0955","unstructured":"PubMed. Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/29654299\/ (accessed June 7, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0960","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1101\/gr.162339.113","article-title":"Analysis of off-target effects of CRISPR\/Cas-derived RNA-guided endonucleases and nickases","volume":"24","author":"Cho","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0965","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nbt.2808","article-title":"Improving CRISPR-Cas nuclease specificity using truncated guide RNAs","volume":"32","author":"Fu","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0970","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1101\/gr.199588.115","article-title":"Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq","volume":"26","author":"Kim","year":"2016","journal-title":"Genome Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0975","article-title":"Genome-wide target specificities of CRISPR RNA-guided programmable deaminases","volume":"35","author":"Kim","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0980","unstructured":"PubMed. Genome-wide profiling of adenine base editor specificity by EndoV-seq (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30622278\/ (accessed June 7, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0985","unstructured":"PubMed. Evaluating and enhancing target specificity of gene-editing nucleases and deaminases, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/30883196\/ (accessed June 7, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0990","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.2559","article-title":"Partial DNA-guided Cas9 enables genome editing with reduced off-target activity","volume":"14","author":"Yin","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb0995","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3389\/fnmol.2018.00413","article-title":"The development of an AAV-based CRISPR SaCas9 genome editing system that can be delivered to neurons in vivo and regulated via doxycycline and Cre-recombinase","volume":"11","author":"Kumar","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1000","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","article-title":"p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells","volume":"24","author":"Ihry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nbt.3190","article-title":"Inhibition of non-homologous end joining increases the efficiency of CRISPR\/Cas9-mediated precise [TM: inserted] genome editing","volume":"33","author":"Maruyama","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/hum.2018.193","article-title":"Somatic gene editing of GUCY2D by AAV-CRISPR\/Cas9 alters retinal structure and function in mouse and macaque","volume":"30","author":"McCullough","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1242\/dev.139683","article-title":"Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos","volume":"144","author":"Plaza Reyes","year":"2017","journal-title":"Development"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJM197109302851405","article-title":"Ethical aspects of genetic controls. Designed genetic changes in man","volume":"285","author":"Fletcher","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1035","series-title":"Society, Ethics, and Technology","first-page":"343","article-title":"The case against perfection","author":"Sandel","year":"2013"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1040","unstructured":"PCBE: Human Dignity and Bioethics: Essays Commissioned by the President's Council on Bioethics (Chapter 11: Human dignity: Exploring and Explicating the Council's Vision), (n.d.). https:\/\/bioethicsarchive.georgetown.edu\/pcbe\/reports\/human_dignity\/chapter11.html (accessed June 14, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ymthe.2006.03.001","article-title":"Genotoxicity of retroviral integration in hematopoietic cells","volume":"13","author":"Nienhuis","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-med-112717-094629","article-title":"Ethics of human genome editing","volume":"70","author":"Coller","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3906\/biy-1912-52","article-title":"Bioethical issues in genome editing by CRISPR-Cas9 technology","volume":"44","author":"Ayano\u011flu","year":"2020","journal-title":"Turk. J. Biol."},{"issue":"2019","key":"10.1016\/j.ijbiomac.2024.134097_bb1060","first-page":"148","article-title":"What academicians need to know?","volume":"10","author":"Lahiry","year":"2017","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/picr.PICR_10_18","article-title":"Indian Council of Medical Research\u2019s National Ethical Guidelines for biomedical and health research involving human participants: the way forward from 2006 to 2017","volume":"10","author":"Behera","year":"2019","journal-title":"Perspect. Clin. Res."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/bfgp\/elv053","article-title":"Germ line genome editing in clinics: the approaches, objectives and global society","volume":"16","author":"Ishii","year":"2017","journal-title":"Brief Funct. Genom."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/21645698.2016.1261787","article-title":"A future scenario of the global regulatory landscape regarding genome-edited crops","volume":"8","author":"Ishii","year":"2017","journal-title":"GM Crops Food"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/533169a","article-title":"Embryology policy: revisit the 14-day rule","volume":"533","author":"Hyun","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41587-019-0077-3","article-title":"Did a permissive scientific culture encourage the \u201cCRISPR babies\u201d experiment?","volume":"37","author":"Dickenson","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1090","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/pbi.13383","article-title":"Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective","volume":"18","author":"Zhang","year":"2020","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1095","author":"National Academies of Sciences, Engineering, and Medicine, National Academy of Medicine, National Academy of Sciences, Committee on Human Gene Editing: Scientific, Medical, and Ethical Considerations, Human Genome Editing: Science, Ethics, and Governance, National Academies Press (US), Washington (DC)"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1100","unstructured":"Human genome editing: recommendations, (n.d.). https:\/\/www.who.int\/publications-detail-redirect\/9789240030381 (accessed June 12, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1105","author":"FOX8 WGHP"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1110","article-title":"Ethical issues in genome editing using Crispr\/Cas9 system","volume":"07","author":"Rodriguez","year":"2016","journal-title":"J. Clin. Res. Bioeth."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3168\/jds.2017-12962","article-title":"Invited review: breeding and ethical perspectives on genetically modified and genome edited cattle","volume":"101","author":"Eriksson","year":"2018","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1120","doi-asserted-by":"crossref","DOI":"10.1002\/fes3.161","article-title":"Impacts of the EU GMO regulatory framework for plant genome editing","volume":"8","author":"Hundleby","year":"2019","journal-title":"Food Energy Secur."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/exd.14555","article-title":"Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa","volume":"31","author":"Thompson","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1130","unstructured":"Nature Cell Biology. Advances in genome editing through control of DNA repair pathways (n.d.). https:\/\/www.nature.com\/articles\/s41556-019-0425-z (accessed April 10, 2024)."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.119.042476","article-title":"In vivo AAV-CRISPR\/Cas9-mediated gene editing ameliorates atherosclerosis in familial hypercholesterolemia","volume":"141","author":"Zhao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","article-title":"Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses","volume":"4","author":"Levy","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1145","doi-asserted-by":"crossref","first-page":"eaan8081","DOI":"10.1126\/scitranslmed.aan8081","article-title":"Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy","volume":"9","author":"Amoasii","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-018-0274-4","article-title":"Long-read sequencing across the C9orf72 \u2018GGGGCC\u2019 repeat expansion: implications for clinical use and genetic discovery efforts in human disease","volume":"13","author":"Ebbert","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10020-020-00244-5","article-title":"Expediting rare disease diagnosis: a call to bridge the gap between clinical and functional genomics","volume":"26","author":"Hartin","year":"2020","journal-title":"Mol. Med."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","article-title":"Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression","volume":"152","author":"Qi","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/brain\/awaa045","article-title":"In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy","volume":"143","author":"Colasante","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03401","article-title":"Concerning RNA-guided gene drives for the alteration of wild populations","volume":"3","author":"Esvelt","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1175","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41590-019-0500-4","article-title":"Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity","volume":"20","author":"Wang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.134097_bb1180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41435-018-0011-6","article-title":"CRISPR\/cas9 mediated knockout of an intergenic variant rs6927172 identified IL-20RA as a new risk gene for multiple autoimmune diseases","volume":"20","author":"Wu","year":"2019","journal-title":"Genes Immun."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404902X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302404902X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T04:58:11Z","timestamp":1724389091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302404902X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":235,"alternative-id":["S014181302404902X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134097","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review on the current status of CRISPR based clinical trials for rare diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134097"}}